A Unique Experimental Treatment Just Got Orphan Drug Designation for Huntington’s Disease
According to a story from Morningstar, the pharmaceutical company Emerald Health Pharmaceuticals announced that its drug candidate EHP-102 was given Orphan Drug Designation by the U.S Food and Drug Administration…